The relative contribution of immunological dysregulation and impaired epithelial barrier function to allergic diseases is still a matter of debate. Here we describe a new syndrome featuring severe dermatitis, multiple allergies and metabolic wasting (SAM syndrome) caused by homozygous mutations in DSG1. DSG1 encodes desmoglein 1, a major constituent of desmosomes, which connect the cell surface to the keratin cytoskeleton and have a crucial role in maintaining epidermal integrity and barrier function. Mutations causing SAM syndrome resulted in lack of membrane expression of DSG1, leading to loss of cell-cell adhesion. In addition, DSG1 deficiency was associated with increased expression of a number of genes encoding allergy-related cytokines. Our deciphering of the pathogenesis of SAM syndrome substantiates the notion that allergy may result from a primary structural epidermal defect.
l e t t e r s
The relative contribution of immunological dysregulation and impaired epithelial barrier function to allergic diseases is still a matter of debate. Here we describe a new syndrome featuring severe dermatitis, multiple allergies and metabolic wasting (SAM syndrome) caused by homozygous mutations in DSG1. DSG1 encodes desmoglein 1, a major constituent of desmosomes, which connect the cell surface to the keratin cytoskeleton and have a crucial role in maintaining epidermal integrity and barrier function. Mutations causing SAM syndrome resulted in lack of membrane expression of DSG1, leading to loss of cell-cell adhesion. In addition, DSG1 deficiency was associated with increased expression of a number of genes encoding allergy-related cytokines. Our deciphering of the pathogenesis of SAM syndrome substantiates the notion that allergy may result from a primary structural epidermal defect.
The epidermis is a stratified squamous epithelium that undergoes a tightly regulated terminal differentiation program culminating in the formation of a functional barrier against environmental agents 1 . Epidermal barrier disruption is thought to have a critical role in the pathogenesis of various allergic disorders 2 . Epidermal cell differentiation and barrier formation are critically dependent on the proper temporal and spatial organization of several intercellular structures 3 . Among these elements, desmosomes are transmembrane structures that connect the cell surface to the intermediate filament cytoskeleton 4 . They consist of heterodimers of desmosomal cadherins, desmogleins (DSG1-DSG4) and desmocollins (DSC1-DSC3), which interact within the intercellular space. The intracytoplasmic part of the desmosomal plaque contains a number of associated proteins, such as plakoglobin and plakophilins, that associate with desmoplakin (DSP) and thereby link to the keratin cytoskeleton. DSG1 has a central role in the pathogenesis of four dermatological conditions 5 : pemphigus foliaceus, an autoimmune blistering disorder caused by autoantibodies directed against DSG1; bullous impetigo and staphylococcal scalded skin syndrome, associated with bacterial production of an exfoliative toxin that specifically targets DSG1; and striate palmoplantar keratoderma striata (PPKS; MIM 148700), a rare autosomal dominant disorder featuring hyperkeratotic plaques along the fingers, palms and soles that is caused by heterozygous mutations in the DSG1 gene.
In the present study, we delineate the molecular basis for a syndrome featuring severe allergic dermatitis and resulting from DSG1 dysfunction, suggesting a role for this molecule in maintaining the integrity of the epidermal barrier. More specifically, we studied three individuals who were referred for investigation because of severe skin dermatitis, multiple allergies and metabolic wasting (SAM) ( Fig. 1 and Table 1 ). The first two affected females were born to healthy first-degree cousins of Arab Muslim descent ( Fig. 2a; family A, II-1 and II-2). Family history was unremarkable. Perinatal course was complicated by severe hypernatremia. The two subjects displayed congenital erythroderma (reminiscent of congenital ichthyosiform erythroderma 6 ), yellowish papules and plaques arranged at the periphery of the palms, along the fingers and over weight-bearing areas of the Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting l e t t e r s feet, skin erosions and scaling, and hypotrichosis (Fig. 1a,b) . In addition, since infancy, they both exhibited severe food allergies, markedly elevated immunoglobulin E (IgE) levels and recurrent infections with marked metabolic wasting. Subject II-1 displayed eosinophilic esophagitis, whereas subject II-2 had severe esophageal reflux and ventricular septal defect. The third affected individual was a 9-monthold female, born to healthy first-degree cousins of Druze descent ( Fig. 2a; family B, IV-10), with congenital erythroderma, severe dermatitis (Fig. 1c) , hypotrichosis ( Fig. 1d) , recurrent skin and respiratory infections, growth retardation and multiple food allergies. Her sister (family B, IV-7) with similar skin and systemic manifestations, elevated IgE levels, microcephaly and a minor cardiac defect (mild pulmonic stenosis) had died at 2 years of age of sepsis. Two additional family members (IV-1 and IV-2) were reported to have succumbed at 2.5 years of age to a similar disorder.
Histopathological examination of skin biopsies from affected individuals showed psoriasiform dermatitis with alternating para-and orthokeratosis, hypo-and hypergranulosis and widespread acantholysis (loss of adhesion between keratinocytes) within the spinous and granular layers, leading to subcorneal and intragranular separation (Fig. 1e,f) . Hair microscopy did not show any specific abnormality (data not shown).
All affected and healthy family members or their legal guardian provided written and informed consent according to a protocol approved by our institutional review boards. The combined occurrence of congenital erythroderma, hypotrichosis, recurrent infections and multiple allergies initially suggested a diagnosis of Netherton syndrome (NTS; MIM 256500). However, no pathogenic mutation could be found in the coding sequence of SPINK5 (encoding LEKTI) in affected individuals from either family, and expression of both LEKTI and filaggrin protein was detected in all biopsies, although it was more diffuse than in control skin ( Supplementary Fig. 1 and Supplementary Data 1). To identify the causative mutations underlying SAM syndrome in the two families, we used DNA of individuals II-1 and II-2 from family A and of individuals IV-7, IV-8, III-2 and IV-10 from family B for whole-exome capture and next-generation sequencing (Online Methods and Supplementary Tables 1 and 2) . We identified two different homozygous mutations in DSG1 in each kindred ( Fig. 2b) : c.49-1G>A in family A and c.1861delG in family B. Using PCR-RFLP, we found that the mutations cosegregated with the disease phenotype in each family (Fig. 2a) . Of note, all heterozygous carriers of the mutations in both families displayed well-demarcated palmoplantar hyperkeratotic papules and plaques, most often not arranged in a striate fashion (Fig. 1g,h ), in agreement with previous data showing that heterozygous mutations in DSG1 can cause either striate, focal or diffuse PPK [7] [8] [9] , associated with keratinocyte disadhesion (but not with frank acantholysis; Supplementary Fig. 2) 10, 11 .
The c.49-1G>A and c.1861delG mutations were excluded from a panel of 170 and 50 population-matched healthy control individuals, respectively, and were absent from the 1000 Genomes Project and the National Heart, Lung, and Blood Institute (NHLBI) Grand Opportunity Exome Sequencing Project databases, including more than 8,200 chromosomes.
Both mutations are likely to result in loss of function. Indeed, c.49-1G>A is predicted (Berkeley Drosophila Genome Project, BDGP) to result in in-frame skipping of exon 2, and c.1861delG is expected to result in frameshift and premature termination of protein translation (p.Ala621Glnfs*3). To confirm these predictions, we extracted RNA from skin biopsies obtained from individual II-1 (family A), individual IV-10 (family B) and a healthy individual (Fig. 2) . npg l e t t e r s Direct sequencing of cDNA confirmed the absence of exon 2 in subject II-1 carrying c.49-1G>A (Fig. 2c) , which is predicted to lead to a 12-amino-acid deletion and to disrupt the DSG1 signal peptide. This signal peptide sequence has been shown to be required for the correct post-translational maturation of DSG3 (ref. 12). To ascertain the effect of the c.49-1G>A mutation at the cellular level, we established keratinocyte cell cultures from subject II-1 from family A. In contrast with control keratinocytes, which demonstrated continuous membrane staining for DSG1, cells from the affected individual showed DSG1 accumulation in the cell cytoplasm, particularly around the nucleus (Fig. 3a) . Immunostaining of skin biopsies from the affected individual also demonstrated cytoplasmic mislocalization of DSG1 compared with control biopsies (Fig. 3b) . Double staining for the endoplasmic reticulum (ER) marker calnexin in cultured cells (Fig. 3a) or the Golgi and endosome marker TGN46 in tissue sections (Fig. 3c) showed partial colocalization of cytoplasmic DSG1 with these endomembrane compartments in the cells from the affected individual.
In contrast with the mutation detected in family A, the c.1861delG mutation was found to be associated with almost absent DSG1 mRNA in the skin (Fig. 2d) , probably reflecting mRNA decay, as previously shown for mRNA with DSG1 heterozygous mutations causing PPKS 10 . Consistent with this observation, staining for DSG1 in a skin biopsy from an affected individual (IV-10, family B) was largely negative (Fig. 3b) . Staining for DSP was retained in affected individuals npg l e t t e r s from both families (Fig. 3b) . Thus, both mutations result in loss of expression of DSG1 at the cell membrane. Of interest, mortality was only recorded in subjects carrying c.1861delG, which results in total absence of DSG1 expression (Fig. 3b) .
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Given the essential role of DSG1 in the formation of desmosomes in the upper epidermis and the presence of acantholysis in all affected individuals (Fig. 1e,f) , we examined desmosome ultrastructure in skin from affected individuals. Electron microscopic examination of skin samples obtained from subjects II-1 (family A) and IV-10 (family B) showed an uneven distribution of desmosomes in the upper epidermis (Fig. 4a) . In contrast, desmosome morphology and distribution appeared normal in the basal and lower spinous layers (Fig. 4b,c) .
Taken together, the above results indicate that SAM syndrome is caused by loss-of-function mutations in DSG1, resulting in impaired desmosome formation in the upper epidermal layers, abnormal differentiation and acantholysis. Although allergic diseases have traditionally been considered to primarily result from immunologic dysregulation 13 , recent data have suggested that impaired epidermal barrier function may also contribute to the development of this group of disorders 2 . Mutations in FLG, encoding filaggrin, a major constituent of the epidermal barrier, have been shown to predispose to atopic diathesis 14 and other T helper cell type 2 (T H 2)-mediated diseases 15 . In contrast with semidominant mutations in FLG, which are only partially penetrant 16 , recessive mutations in SPINK5, encoding the serine protease inhibitor LEKTI, and in CDSN, encoding corneodesmosin, are fully penetrant and have been shown to cause NTS 17 and peeling skin syndrome type B (PSS-B; MIM 270300) 18 , respectively. Interestingly, NTS, PSS-B and SAM syndrome share numerous clinical features (Supplementary Fig. 3 ). In addition, both NTS and PSS-B are characterized by superficial intraepidermal detachment similar to that seen in individuals with SAM syndrome (although frank acantholysis is not observed in either disease) as well as by a heightened T H 2 immune response 17, 18 . DSG1 and corneodesmosin are major components of corneodesmosomes, which are responsible for ensuring cohesiveness within the stratum corneum 19 . Degradation of these two proteins is pivotal for epidermal desquamation, a process that is tightly regulated by epidermal proteases and protease inhibitors such as LEKTI 20 . These data may explain why these three disorders share common phenotypic features, as decreased LEKTI activity or decreased corneodesmosin and/or DSG1 expression are similarly expected to result in accelerated desquamation 21, 22 . Loss of DSG1 is also likely to interfere with epidermal differentiation by sustaining extracellular signal-regulated kinase 1 and 2 (ERK1/2) signaling suprabasally 23 .
Thus, this report and these previous data demarcate a new group of disorders characterized by aberrant cell-cell adhesion in the upper epidermal layers, resulting in compromised barrier function 2 , which in turn may expose the immune system to abnormal stimulation, leading to multiple allergies, as barrier dysfunction enhances systemic T H 2 responses 24 . Alternatively, we cannot exclude a role for DSG1 deficiency in stimulating T H 2 cytokine production, as previously shown for other elements of the epidermal barrier 25 . In this regard, it is of interest that the expression of TSLP, IL5 and TNF, encoding mediators involved in skin allergy 26, 27 , was elevated in keratinocytes from affected individuals (Fig. 5) .
With regard to other manifestations of SAM syndrome, minor cardiac developmental defects were noted in two affected individuals, a characteristic that is reminiscent of an association between desmosomal diseases and cardiac conditions 28 . The mechanisms underlying metabolic wasting in SAM syndrome remain to be fully delineated. Although defective epidermal barrier is usually blamed for impaired growth and caloric losses in ichthyoses 29, 30 , malabsorption and enteropathy have been reported in NTS 31 , which is pathogenetically related to SAM syndrome (Supplementary Fig. 3 ). Given that we observed esophageal involvement in two subjects (Table 1) , which may be related to strong DSG1 expression in the esophagus ( Supplementary  Fig. 4) , that TSLP was upregulated in cells from affected individuals and that TSLP has been shown to induce allergic manifestations in the gastrointestinal tract 32 , a direct role for DSG1 deficiency in mediating metabolic wasting in SAM syndrome cannot be excluded.
Taken together, the present data substantiate the notion that allergy may result from a primary epidermal defect. 
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Subjects. All affected and healthy family members or their legal guardians provided written and informed consent according to a protocol approved by our institutional review board and by the Israel National Committee for Human Genetic Studies in adherence to the Helsinki guidelines (Supplementary Note). The investigators were not blinded to allocation during experiments and outcome assessment.
Exome sequencing. EDTA-treated blood samples were obtained from affected individuals and their healthy family members. Genomic DNA was extracted from peripheral blood leukocytes using the 5 Prime ArchivePure DNA Blood kit (5 Prime). Exome sequencing of affected individuals from family A was performed at King's College London. Whole-exome capture was carried out by in-solution hybridization with SureSelect All Exon 50Mb Version 4.0 (Agilent) followed by massively parallel sequencing (Illumina HiSeq2000) with 100-bp paired-end reads. Duplicate reads, resulting from PCR clonality or optical duplicates, and reads mapping to multiple locations were excluded from downstream analysis. Single-nucleotide substitutions and small insertion-deletions were identified and quality filtered with the SAMtools software package and in-house software. Variants were annotated with respect to genes and transcripts with the ANNOVAR tool. Identified variants were cross-referenced with publicly available variant data (dbSNP135 and 1000 Genomes Project). Supplementary Table 1 summarizes the exome sequencing details for family A.
Exome sequencing in family B was performed by BGI Tech Solutions. Whole-exome capture was carried out with the SeqCap EZ Human Exome Library v3.0 (NimbleGen) followed by massively parallel sequencing (Illumina HiSeq2000) with 90-bp paired-end reads. Reads were aligned to the Genome Reference Consortium Human Build 37 (GRCh37/hg19) using BurrowsWheeler Aligner (BWA) 33 . Duplicate reads, resulting from PCR clonality or optical duplicates, and reads mapping to multiple locations were excluded from downstream analysis. Reads mapping to a region of known or detected insertions or deletions were realigned to minimize alignment errors. Singlenucleotide substitutions and small insertion-deletions were identified and quality filtered using the Genome Analysis Tool Kit (GATK) 34 . Rare variants were identified by filtering using the data from dbSNP135, the 1000 Genomes Project, the Exome Variant Server (see URLs) and an in-house database of sequenced individuals. Variants were classified by predicted protein effects using PolyPhen-2 (ref. 35 ) and SIFT 36 . Supplementary Table 2 summarizes exome sequencing details for family B.
Mutation analysis. Genomic DNA was PCR amplified using oligonucleotide primer pairs spanning the entire coding sequence as well as the intron-exon boundaries of DSG1 (Supplementary Table 3 ) and ReddyMix PCR Master Mix (Thermo Scientific). Cycling conditions were as follows: 95 °C for 4 min followed by 34 cycles of 95 °C for 30 s, 60 °C for 45 s and 72 °C for 90 s (for exons 1, 6, 12, 15_1, 15_2 and 15_3) and 95 °C for 4 min followed by 34 cycles of 95 °C for 30 s, 52 °C for 45 s and 72 °C for 90 s (for exons 2-5, 7-11, 13, 14 and 15_4). Gel-purified (QIAquick Gel Extraction kit, Qiagen) amplicons were subjected to bidirectional DNA sequencing with the BigDye Terminator system on an ABI Prism 3100 sequencer (Applied Biosystems).
PCR-RFLP.
To screen for the c.49-1G>A mutation, we PCR amplified a 247-bp fragment (for primer sequences, see Supplementary Table 3) . The mutation abolishes a recognition site for the EcoNI endonuclease (New England BioLabs). To screen for the c.1861delG mutation, we PCR amplified a 312-bp fragment (for primer sequences, see Supplementary Table 3 ). The mutation abolishes a recognition site for the BstUI endonuclease (New England BioLabs). In both cases, after incubation at 37 °C for 8 h with the corresponding endonuclease, digested PCR products were electrophoresed in ethidium bromide-stained 3% agarose gels.
Cell cultures and reagents. Keratinocyte cell cultures were established from punch biopsies obtained from subject II-1 from family A and healthy controls after written informed consent was obtained and were maintained in Keratinocyte Growth Medium (KGM) supplemented with 0.4% bovine pituitary extract, 0.1% human epidermal growth factor (hEGF), 0.1% insulin, 0.1% hydrocortisone and 0.1% gentamicin/amphotericin B (all purchased from Lonza).
Quantitative RT-PCR. For quantitative RT-PCR, cDNA was synthesized from 500 ng of total RNA using the qScript kit (Quanta Biosciences). PCR amplification of cDNA was carried out with PerfeCTa SYBR Green FastMix (Quanta Biosciences) on a StepOnePlus system (Applied Biosystems) with genespecific intron-spanning oligonucleotide pairs (Supplementary Table 3) . Cycling conditions were as follows: 95 °C for 30 s followed by 40 cycles of 95 °C for 4 s and 60 °C for 30 s. Each sample was analyzed in triplicate. For quantification, standard curves were obtained with serially diluted cDNA amplified in the same RT-PCR run. Results were normalized to ACTB mRNA levels.
Immunohistochemistry. For staining of LEKTI and filaggrin, formaldehydefixed 5-µm paraffin-embedded sections were mounted on SuperFrostPlus glass (Menzel-Glazer) and processed using an automated immunostainer (Benchmark-XT, Ventana Medical System). Visualization of the bound primary antibodies was performed using the I-View DAB detection kit (Ventana Medical System). Sections were then counterstained with Gill's hematoxylin, dehydrated and mounted for microscopic examination. The primary antibodies used were a monoclonal mouse antibody to human LEKTI (diluted 1:25) (C11G61, Santa Cruz Biotechnology) and a monoclonal mouse antibody to human filaggrin (diluted 1:40) (C1015, Novocastra).
Immunostaining of keratinocytes and skin biopsies. Keratinocytes that were collected from punch biopsies were grown on glass coverslips and fixed with 4% paraformaldehyde. For immunofluorescence analysis of skin biopsies, 3-to 5-µm paraffin-embedded sections were baked overnight at 60 °C and deparaffinized using xylene/ethanol. After permeabilization with 0.5% Triton X-100 in PBS, antigen retrieval was accomplished using 0.01 M citrate buffer, pH 6.0. Sections were blocked in 1% BSA and 2% normal goat serum for 1 h at 37 °C. Primary antibodies were diluted in 1% BSA and 2% normal goat serum and incubated overnight with samples at 4 °C. Primary antibodies used were 4B2 (desmoglein 1) (diluted 1:100) 37 , 11-5F (DSP; a gift from D. Garrod) (diluted 1:100) and TGN46 (diluted 1:100) (PAB0110, Abnova). Secondary antibody staining was carried out for 30 min at 37 °C using Alexa Fluor-conjugated secondary antibody to mouse or rabbit (Life Technologies/ Invitrogen). Coverslips were mounted in polyvinyl alcohol for microscopic observation using a DMR Leica microscope (40× NA 1.0 Plan-Fluotar Plan-Apochromat objective) and a charge-coupled device camera (Orca 100 model C47 42-95; Hamamatsu Photonics) for fluorescence image acquisition. For double-label immunofluorescence colocalization with TGN46, optical sections were obtained using a 63× NA 1.4 Plan-Apochromat objective on an AxioVision Z1 (Carl Zeiss) fitted with an Apotome slide module and a digital camera (AxioCam MRm; Carl Zeiss).
Electron microscopy. Skin biopsies were fixed in half-strength Karnowski's fixative and 1% osmium tetroxide. Tissue blocks were dehydrated with ethanol, stained en bloc using 1% uranyl acetate in 50% ethanol and embedded in Epon resin (TAAB, Aldermaton). Ultrathin sections were stained with 1.5% uranyl acetate in methanol and Reynold's lead citrate and were examined with a JEM-1010 transmission electron microscope (Jeol).
